IBX 2.56% 3.8¢ imagion biosystems limited

General Chat, page-13

  1. 653 Posts.
    lightbulb Created with Sketch. 174
    Phase 1 is First in human study, approximately 20 patients. Due to start this month.
    If results demonstrate safe administration and tolerance in humans, a larger commercial study will commence for approximately 300 participants. This is phase 2 and should commence 2021. Subject to FDA approval, full commercial testing is not that far away, providing phase 1 goes according to plan. AIMO.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $1.329M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $2.593K 68.23K

Buyers (Bids)

No. Vol. Price($)
1 16000 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 6078 1
View Market Depth
Last trade - 10.15am 06/08/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.